🇺🇸 FDA
Patent

US 11426379

Combination of local and systemic therapies for enhanced treatment of dermatologic conditions

granted A61KA61K31/352A61K31/4035

Quick answer

US patent 11426379 (Combination of local and systemic therapies for enhanced treatment of dermatologic conditions) held by Provectus Pharmatech, Inc. expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provectus Pharmatech, Inc.
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/352, A61K31/4035, A61K31/519, A61K31/52